APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivonescimab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ivonescimab Injection Market Analysis and Forecast 2026-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchIvonescimab Injection Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivonescimab Injection Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Ivonescimab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivonescimab Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivonescimab Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Ivonescimab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ivonescimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ivonescimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ivonescimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ivonescimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ivonescimab Injection include Akeso Inc. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ivonescimab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ivonescimab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Ivonescimab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ivonescimab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ivonescimab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ivonescimab Injection sales, projected growth trends, production technology, application and end-user industry.

Ivonescimab Injection Segment by Company

Akeso Inc

Ivonescimab Injection Segment by Type

100 mg (10mL)/Bottle

Other

Ivonescimab Injection Segment by Application

Hospital

Clinic

Other

Ivonescimab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivonescimab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivonescimab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivonescimab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ivonescimab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ivonescimab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ivonescimab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ivonescimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100 mg (10mL)/Bottle Major Manufacturers Table 3. Other Major Manufacturers Table 4. Global Ivonescimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Ivonescimab Injection Industry Trends Table 9. Ivonescimab Injection Industry Drivers Table 10. Ivonescimab Injection Industry Opportunities and Challenges Table 11. Ivonescimab Injection Industry Restraints Table 12. Global Ivonescimab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Ivonescimab Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Ivonescimab Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Ivonescimab Injection Revenue Market Share by Region (2021-2026) Table 16. Global Ivonescimab Injection Revenue Market Share by Region (2027-2032) Table 17. Global Ivonescimab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Ivonescimab Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Ivonescimab Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Ivonescimab Injection Sales Market Share by Region (2021-2026) Table 21. Global Ivonescimab Injection Sales Market Share by Region (2027-2032) Table 22. Global Ivonescimab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Ivonescimab Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Ivonescimab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ivonescimab Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Ivonescimab Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Ivonescimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Ivonescimab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Ivonescimab Injection Manufacturers, Product Type & Application Table 30. Global Ivonescimab Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Ivonescimab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Ivonescimab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ivonescimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Ivonescimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Ivonescimab Injection Revenue Market Share by Type (2021-2026) Table 37. Global Ivonescimab Injection Revenue Market Share by Type (2027-2032) Table 38. Global Ivonescimab Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Ivonescimab Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Ivonescimab Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Ivonescimab Injection Sales Market Share by Type (2021-2026) Table 42. Global Ivonescimab Injection Sales Market Share by Type (2027-2032) Table 43. Global Ivonescimab Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Ivonescimab Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Ivonescimab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Ivonescimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Ivonescimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Ivonescimab Injection Revenue Market Share by Application (2021-2026) Table 49. Global Ivonescimab Injection Revenue Market Share by Application (2027-2032) Table 50. Global Ivonescimab Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Ivonescimab Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ivonescimab Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Ivonescimab Injection Sales Market Share by Application (2021-2026) Table 54. Global Ivonescimab Injection Sales Market Share by Application (2027-2032) Table 55. Global Ivonescimab Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ivonescimab Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Akeso Inc Company Information Table 58. Akeso Inc Business Overview Table 59. Akeso Inc Ivonescimab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Akeso Inc Ivonescimab Injection Product Portfolio Table 61. Akeso Inc Recent Development Table 62. North America Ivonescimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Ivonescimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Ivonescimab Injection Sales by Type (2021-2026) & (K Units) Table 65. North America Ivonescimab Injection Sales by Type (2027-2032) & (K Units) Table 66. North America Ivonescimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 67. North America Ivonescimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 68. North America Ivonescimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Ivonescimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Ivonescimab Injection Sales by Application (2021-2026) & (K Units) Table 71. North America Ivonescimab Injection Sales by Application (2027-2032) & (K Units) Table 72. North America Ivonescimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 73. North America Ivonescimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 74. North America Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Ivonescimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 76. North America Ivonescimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 77. North America Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 78. North America Ivonescimab Injection Sales by Country (2021-2026) & (K Units) Table 79. North America Ivonescimab Injection Sales by Country (2027-2032) & (K Units) Table 80. North America Ivonescimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 81. North America Ivonescimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 82. United States Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 83. Canada Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 84. Mexico Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 85. Europe Ivonescimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe Ivonescimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe Ivonescimab Injection Sales by Type (2021-2026) & (K Units) Table 88. Europe Ivonescimab Injection Sales by Type (2027-2032) & (K Units) Table 89. Europe Ivonescimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 90. Europe Ivonescimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 91. Europe Ivonescimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Ivonescimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Ivonescimab Injection Sales by Application (2021-2026) & (K Units) Table 94. Europe Ivonescimab Injection Sales by Application (2027-2032) & (K Units) Table 95. Europe Ivonescimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 96. Europe Ivonescimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 97. Europe Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Ivonescimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. Europe Ivonescimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. Europe Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 101. Europe Ivonescimab Injection Sales by Country (2021-2026) & (K Units) Table 102. Europe Ivonescimab Injection Sales by Country (2027-2032) & (K Units) Table 103. Europe Ivonescimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 104. Europe Ivonescimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 105. Germany Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 106. France Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 107. U.K. Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 108. Italy Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 109. Russia Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 110. Spain Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 111. Netherlands Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 112. Switzerland Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 113. Sweden Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 114. Poland Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 115. China Ivonescimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 116. China Ivonescimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 117. China Ivonescimab Injection Sales by Type (2021-2026) & (K Units) Table 118. China Ivonescimab Injection Sales by Type (2027-2032) & (K Units) Table 119. China Ivonescimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 120. China Ivonescimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 121. China Ivonescimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 122. China Ivonescimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 123. China Ivonescimab Injection Sales by Application (2021-2026) & (K Units) Table 124. China Ivonescimab Injection Sales by Application (2027-2032) & (K Units) Table 125. China Ivonescimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 126. China Ivonescimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Asia Ivonescimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Ivonescimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Ivonescimab Injection Sales by Type (2021-2026) & (K Units) Table 130. Asia Ivonescimab Injection Sales by Type (2027-2032) & (K Units) Table 131. Asia Ivonescimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Asia Ivonescimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Asia Ivonescimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Ivonescimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Ivonescimab Injection Sales by Application (2021-2026) & (K Units) Table 136. Asia Ivonescimab Injection Sales by Application (2027-2032) & (K Units) Table 137. Asia Ivonescimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Asia Ivonescimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Ivonescimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia Ivonescimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. Asia Ivonescimab Injection Sales by Country (2021-2026) & (K Units) Table 144. Asia Ivonescimab Injection Sales by Country (2027-2032) & (K Units) Table 145. Asia Ivonescimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Asia Ivonescimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Japan Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 148. South Korea Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 149. India Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 150. Australia Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 151. Taiwan Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 153. SAMEA Ivonescimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Ivonescimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Ivonescimab Injection Sales by Type (2021-2026) & (K Units) Table 156. SAMEA Ivonescimab Injection Sales by Type (2027-2032) & (K Units) Table 157. SAMEA Ivonescimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 158. SAMEA Ivonescimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 159. SAMEA Ivonescimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA Ivonescimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA Ivonescimab Injection Sales by Application (2021-2026) & (K Units) Table 162. SAMEA Ivonescimab Injection Sales by Application (2027-2032) & (K Units) Table 163. SAMEA Ivonescimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 164. SAMEA Ivonescimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 165. SAMEA Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Ivonescimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA Ivonescimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. SAMEA Ivonescimab Injection Sales by Country (2021-2026) & (K Units) Table 170. SAMEA Ivonescimab Injection Sales by Country (2027-2032) & (K Units) Table 171. SAMEA Ivonescimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 172. SAMEA Ivonescimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Brazil Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 174. Argentina Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 175. Chile Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 176. Colombia Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 177. Peru Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 179. Israel Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 180. UAE Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 181. Turkey Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 182. Iran Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 183. Egypt Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Ivonescimab Injection Distributors List Table 187. Ivonescimab Injection Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Ivonescimab Injection Image Figure 2. Global Ivonescimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivonescimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100 mg (10mL)/Bottle Image Figure 5. Other Image Figure 6. Global Ivonescimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ivonescimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Ivonescimab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ivonescimab Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Ivonescimab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Ivonescimab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Ivonescimab Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Ivonescimab Injection Sales (2021-2032) & (K Units) Figure 17. Global Ivonescimab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Ivonescimab Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Ivonescimab Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Ivonescimab Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Ivonescimab Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Ivonescimab Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Ivonescimab Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Ivonescimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Ivonescimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Ivonescimab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Ivonescimab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Ivonescimab Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Ivonescimab Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Ivonescimab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Ivonescimab Injection Sales Market Share by Type (2021-2032) Figure 33. Global Ivonescimab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Ivonescimab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Ivonescimab Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Ivonescimab Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Ivonescimab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Ivonescimab Injection Sales Market Share by Application (2021-2032) Figure 39. North America Ivonescimab Injection Revenue Share by Type (2021-2032) Figure 40. North America Ivonescimab Injection Sales Share by Type (2021-2032) Figure 41. North America Ivonescimab Injection Revenue Share by Application (2021-2032) Figure 42. North America Ivonescimab Injection Sales Share by Application (2021-2032) Figure 43. North America Ivonescimab Injection Revenue Share by Country (2021-2032) Figure 44. North America Ivonescimab Injection Sales Share by Country (2021-2032) Figure 45. Europe Ivonescimab Injection Revenue Share by Type (2021-2032) Figure 46. Europe Ivonescimab Injection Sales Share by Type (2021-2032) Figure 47. Europe Ivonescimab Injection Revenue Share by Application (2021-2032) Figure 48. Europe Ivonescimab Injection Sales Share by Application (2021-2032) Figure 49. Europe Ivonescimab Injection Revenue Share by Country (2021-2032) Figure 50. Europe Ivonescimab Injection Sales Share by Country (2021-2032) Figure 51. China Ivonescimab Injection Revenue Share by Type (2021-2032) Figure 52. China Ivonescimab Injection Sales Share by Type (2021-2032) Figure 53. China Ivonescimab Injection Revenue Share by Application (2021-2032) Figure 54. China Ivonescimab Injection Sales Share by Application (2021-2032) Figure 55. Asia Ivonescimab Injection Revenue Share by Type (2021-2032) Figure 56. Asia Ivonescimab Injection Sales Share by Type (2021-2032) Figure 57. Asia Ivonescimab Injection Revenue Share by Application (2021-2032) Figure 58. Asia Ivonescimab Injection Sales Share by Application (2021-2032) Figure 59. Asia Ivonescimab Injection Revenue Share by Country (2021-2032) Figure 60. Asia Ivonescimab Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Ivonescimab Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Ivonescimab Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Ivonescimab Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Ivonescimab Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Ivonescimab Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Ivonescimab Injection Sales Share by Country (2021-2032) Figure 67. Ivonescimab Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ivonescimab Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg (10mL)/Bottle
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Akeso Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ivonescimab Injection Market by Type
  3. 1.2.1 Global Ivonescimab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100 mg (10mL)/Bottle
  5. 1.2.3 Other
  6. 1.3 Ivonescimab Injection Market by Application
  7. 1.3.1 Global Ivonescimab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ivonescimab Injection Market Dynamics
  1. 2.1 Ivonescimab Injection Industry Trends
  2. 2.2 Ivonescimab Injection Industry Drivers
  3. 2.3 Ivonescimab Injection Industry Opportunities and Challenges
  4. 2.4 Ivonescimab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ivonescimab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ivonescimab Injection Revenue by Region
  3. 3.2.1 Global Ivonescimab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ivonescimab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Ivonescimab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Ivonescimab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ivonescimab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ivonescimab Injection Sales by Region
  9. 3.4.1 Global Ivonescimab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ivonescimab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Ivonescimab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Ivonescimab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ivonescimab Injection Revenue by Manufacturers
  2. 4.1.1 Global Ivonescimab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ivonescimab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ivonescimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ivonescimab Injection Sales by Manufacturers
  6. 4.2.1 Global Ivonescimab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ivonescimab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ivonescimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ivonescimab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ivonescimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ivonescimab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ivonescimab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Ivonescimab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ivonescimab Injection Market CR5 and HHI
  16. 4.8.2 2025 Ivonescimab Injection Tier 1, Tier 2, and Tier 3
5 Ivonescimab Injection Market by Type
  1. 5.1 Global Ivonescimab Injection Revenue by Type
  2. 5.1.1 Global Ivonescimab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ivonescimab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ivonescimab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ivonescimab Injection Sales by Type
  6. 5.2.1 Global Ivonescimab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ivonescimab Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ivonescimab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ivonescimab Injection Price by Type
6 Ivonescimab Injection Market by Application
  1. 6.1 Global Ivonescimab Injection Revenue by Application
  2. 6.1.1 Global Ivonescimab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ivonescimab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ivonescimab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ivonescimab Injection Sales by Application
  6. 6.2.1 Global Ivonescimab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ivonescimab Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ivonescimab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ivonescimab Injection Price by Application
7 Company Profiles
  1. 7.1 Akeso Inc
  2. 7.1.1 Akeso Inc Company Information
  3. 7.1.2 Akeso Inc Business Overview
  4. 7.1.3 Akeso Inc Ivonescimab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Akeso Inc Ivonescimab Injection Product Portfolio
  6. 7.1.5 Akeso Inc Recent Developments
8 North America
  1. 8.1 North America Ivonescimab Injection Market Size by Type
  2. 8.1.1 North America Ivonescimab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Ivonescimab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Ivonescimab Injection Price by Type (2021-2032)
  5. 8.2 North America Ivonescimab Injection Market Size by Application
  6. 8.2.1 North America Ivonescimab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Ivonescimab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Ivonescimab Injection Price by Application (2021-2032)
  9. 8.3 North America Ivonescimab Injection Market Size by Country
  10. 8.3.1 North America Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ivonescimab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ivonescimab Injection Market Size by Type
  2. 9.1.1 Europe Ivonescimab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ivonescimab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Ivonescimab Injection Price by Type (2021-2032)
  5. 9.2 Europe Ivonescimab Injection Market Size by Application
  6. 9.2.1 Europe Ivonescimab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ivonescimab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Ivonescimab Injection Price by Application (2021-2032)
  9. 9.3 Europe Ivonescimab Injection Market Size by Country
  10. 9.3.1 Europe Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ivonescimab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ivonescimab Injection Market Size by Type
  2. 10.1.1 China Ivonescimab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Ivonescimab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Ivonescimab Injection Price by Type (2021-2032)
  5. 10.2 China Ivonescimab Injection Market Size by Application
  6. 10.2.1 China Ivonescimab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Ivonescimab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Ivonescimab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ivonescimab Injection Market Size by Type
  2. 11.1.1 Asia Ivonescimab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ivonescimab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Ivonescimab Injection Price by Type (2021-2032)
  5. 11.2 Asia Ivonescimab Injection Market Size by Application
  6. 11.2.1 Asia Ivonescimab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ivonescimab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Ivonescimab Injection Price by Application (2021-2032)
  9. 11.3 Asia Ivonescimab Injection Market Size by Country
  10. 11.3.1 Asia Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ivonescimab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ivonescimab Injection Market Size by Type
  2. 12.1.1 SAMEA Ivonescimab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ivonescimab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ivonescimab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Ivonescimab Injection Market Size by Application
  6. 12.2.1 SAMEA Ivonescimab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ivonescimab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ivonescimab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Ivonescimab Injection Market Size by Country
  10. 12.3.1 SAMEA Ivonescimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ivonescimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ivonescimab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ivonescimab Injection Value Chain Analysis
  2. 13.1.1 Ivonescimab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ivonescimab Injection Production Mode & Process
  6. 13.2 Ivonescimab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ivonescimab Injection Distributors
  9. 13.2.3 Ivonescimab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst